UBE2L6 and acute promyelocytic leukemia: Ubiquitin-conjugating enzyme E2 L6 (UBE2L6), an IFN-inducible ubiquitin E2, modulates ISGylation in leukemic cells to strongly interfere with the neutrophil differentiation of ATRA-treated APL cells [29].